BitFrontier Capital Holdings, Inc. (OTCID: BFCH), operating as UNLOCKD Inc., has announced the successful closing of its acquisition of VerdaGenix, LLC, owner and operator of the Ancient Extracts USA wellness platform. The transaction, finalized under definitive documents, makes Ancient Extracts a wholly owned subsidiary of BFCH, adding established commercial operations, proprietary formulations, intellectual property, and a diversified catalogue of more than 20 wellness SKUs already in the market.
Management believes this acquisition represents a defining milestone in BFCH's evolution into a scalable operating platform focused on wellness, performance, functional products, and human optimization. The deal follows a series of strategic developments over the past year, including the elimination of over $2 million in legacy convertible debt, strengthened balance sheet and governance, restored disclosure compliance, and the acquisition of the EVERMIND™ intellectual property platform.
The company is now shifting focus to commercializing and expanding Ancient Extracts, scaling both direct-to-consumer operations and retail distribution. BFCH confirmed it is advancing growth capital initiatives to support inventory expansion, customer acquisition, and retail channel development. Management emphasized that the completion of the acquisition de-risks the broader operating strategy by establishing an active commercial foundation upon which future growth can be accelerated.
John P. Gorst, CEO of BFCH, stated: "We are not attempting to create a concept from scratch. Ancient Extracts already has operating infrastructure, commercialized products, existing customers, active distribution channels, and a brand foundation capable of meaningful expansion. Our focus now is execution, commercialization scale, and building a significantly larger operating platform around assets we believe possess real long-term value." He added that the combination of operational infrastructure, governance improvements, and capital markets initiatives occurring simultaneously is compelling.
Jordan P. Balencic, D.O., Chairman and Chief Science Officer, commented: "Closing Ancient Extracts represents a transformational milestone for BFCH and UNLOCKD. The foundation now being established is significantly stronger than many investors currently appreciate. Our focus now shifts from corporate restructuring and platform assembly toward commercialization, operational execution, and long-term value creation."
The company also confirmed management is actively evaluating additional acquisition opportunities and strategic partnerships aligned with its long-term strategy. Separately, BFCH received a formal legal opinion concluding that it is not a shell company under Rule 405 of the Securities Act of 1933, based on its operating strategy, asset base, and acquisitions. For corporate information, visit www.UNLOCKDinc.com. View current filings on OTC Markets.
